Bishops urge EU not to fund embryonic stem-cell research
December 16, 2011
The Commission of the Bishops’ Conferences of the European Community is urging the European Union not to fund embryonic stem-cell research in Horizon 2020, its $104-billion research program for 2014 to 2020.
“Recently, Geron Corp., the world’s leading embryo research company, announced it was closing down its stem cell program,” COMECE stated. “As a matter of fact, human embryonic stem cell research has not delivered the expected results. In the meantime, research on alternative sources of stem cells--adult, umbilical cord blood or induced pluripotent--offer real, effective prospects for therapeutic applications or have indeed already demonstrated widespread clinical results.”
“These methods, because they enjoy wide acceptance--both on scientific and ethical grounds--are not controversial among member states. They should therefore be prioritized in the context of EU funding.”
All comments are moderated. To lighten our editing burden, only current donors are allowed to Sound Off. If you are a donor, log in to see the comment form; otherwise please support our work, and Sound Off!